Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-001606
Filing Date
2023-02-16
Accepted
2023-02-16 14:30:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27674
2 filename2.txt TEXT-EXTRACT 1541
  Complete submission text file 0000000000-23-001606.txt   40344
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filed for) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations